Early Diagnosis and Management for a Better Life
Early identification and management of COPD can have a significant public health impact.
November 18, 2026
GLENVIEW, IL – Chronic obstructive pulmonary disease (COPD) claims around 3
million lives worldwide every year and remains a major global respiratory
health challenge. Although preventable and treatable, the disease is
frequently underdiagnosed, meaning millions of people may be missing
opportunities for earlier diagnosis and effective care.1
Ahead of World COPD Day on November 18, 2026, the Forum of International
Respiratory Societies (FIRS), of which the American College of Chest
Physicians (CHEST) is a member, is emphasizing the importance of recognizing
COPD earlier and improving treatment access. This year’s World COPD Day
theme, led by the Global Initiative for Chronic Obstructive Lung Disease
(GOLD), is
“Early Diagnosis and Management for a Better Life.”
COPD is common and treatable, but extensive under- and misdiagnosis leads to
patients receiving treatment later in the disease course. Many factors can
lead to delayed diagnosis of COPD, including patient-, health care system-,
and provider-related factors. Patients may not recognize or report symptoms
accurately, health care systems may not have resources to adequately train
staff in respiratory health or provide adequate access to spirometry within
their communities, and providers may have a poor understanding of COPD
diagnostic criteria.
Health care providers should look for factors that may place their adult
patients at increased risk of COPD such as the following:
-
Exposure to risk factors (tobacco smoke, household and outdoor air
pollution, occupational exposures)
-
Recurrent chest infections
-
Genetic factors
-
Prematurity and early life disadvantage factors
-
Respiratory symptoms, including shortness of breath or chronic cough
Accurate and timely diagnosis of COPD can improve patients’ quality of life
and health outcomes. Based on currently available evidence, GOLD advocates
for active case finding, including performing spirometry in individuals with
symptoms or risk factors, or both.2
In addition to providing earlier diagnosis, earlytreatment
of COPD can slow disease progression, reduce symptom burden, and prevent
future exacerbations. Intervention at an earlier stage, especially in
symptomatic individuals or those with evidence of airflow limitation, can
meaningfully improve long‑term outcomes. Prompt initiation of appropriate
bronchodilator therapy, smoking cessation support, and risk‑factor reduction
can help preserve lung function and enhance quality of life.
Resources:
About World COPD Day
World COPD Day is an annual global initiative run by the Global Initiative
for Chronic Obstructive Lung Disease (GOLD), a member of the Forum of
International Respiratory Societies (FIRS). The goal of World COPD Day is to
raise awareness and present new knowledge and therapeutic strategies for
COPD worldwide. The 25th annual World COPD Day will take place on November
18, 2026. Be part of the global effort to improve the lives of people with
COPD. Join World COPD Day events organized by GOLD and FIRS. Find out more
here.
About the American College of Chest Physicians
The American College of Chest Physicians®(CHEST)
is the global leader in the prevention, diagnosis, and treatment of chest
diseases. Its mission is to champion the prevention, diagnosis, and
treatment of chest diseases through education, communication, and research.
It serves as an essential connection to clinical knowledge and resources for
its 18,000+ members from around the world who provide patient care in
pulmonary, critical care, and sleep medicine. For information about CHEST
and its family of journals, including the flagship journal CHEST,
visit chestnet.org.
About the Forum of International Respiratory Societies
The Forum of International Respiratory Societies
(FIRS) is an organization consisting of the world’s leading international
respiratory societies working together to improve lung health globally:
American College of Chest Physicians
(CHEST), American Thoracic Society
(ATS), Asian Pacific Society of Respirology
(APSR),
Asociación Latinoamericana De Tórax
(ALAT), European Respiratory Society
(ERS),
International Union Against Tuberculosis and Lung Disease
(The Union),
Pan African Thoracic Society
(PATS), Global Initiative for Asthma
(GINA), and the
Global Initiative for Chronic Obstructive Lung Disease
(GOLD) .
References
1. Lytras T, Kogevinas M, Kromhout H, et al. Occupational exposures and 20-year incidence of COPD: the European Community Respiratory Health Survey. Thorax. 2018;73(11): 1008-1015. https://pubmed.ncbi.nlm.nih.gov/29574416
2. Martinez CH, Mannino DM, Jaimes FA, et al. Undiagnosed obstructive lung disease in the United States: associated factors and long-term mortality. Ann Am Thorac Soc. 2015;12(12):1788-1795.